venBio Partners’s Checkmate Pharmaceuticals, Inc. Common Stock CMPI Stock Holding History

venBio Partners’s Portfolio CMPI Stock Details CMPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,673,374	Closed	-$11.7M	–	10
2022 Q1	$11.7M	Hold	3,673,374	–	–	2.6%	8
2021 Q4	$10.5M	Hold	3,673,374	–	–	1.9%	8
2021 Q3	$14.6M	Hold	3,673,374	–	–	1.45%	7
2021 Q2	$21.9M	Hold	3,673,374	–	–	2.58%	8
2021 Q1	$44.6M	Hold	3,673,374	–	–	4.24%	5
2020 Q4	$53.6M	Hold	3,673,374	–	–	4.73%	4
2020 Q3	$42.3M	Buy	+3,673,374	New	+$47.1M	6.43%	4

venBio Partners's CMPI Position: Q2 2022 in Review

venBio Partners sold out of Checkmate Pharmaceuticals, Inc. Common Stock (CMPI) in Q2 2022, closing a stake of 3,673,374 shares — an estimated $11.7M sold.

venBio Partners first reported a position in CMPI in Q3 2020 and held it in 7 quarters. The position peaked at $53.6M in Q4 2020. 0 funds tracked by Wall St. Rank hold CMPI as of Q2 2022.

venBio Partners reported no remaining Checkmate Pharmaceuticals, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
venBio Partners sold 3,673,374 Checkmate Pharmaceuticals, Inc. Common Stock shares in Q2 2022, an estimated $11.7M.
venBio Partners first reported a position in Checkmate Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 7 quarters.
venBio Partners's Checkmate Pharmaceuticals, Inc. Common Stock position peaked at $53.6M in Q4 2020.
0 funds tracked by Wall St. Rank held Checkmate Pharmaceuticals, Inc. Common Stock as of Q2 2022.

Based on venBio Partners's 13F filing for Q2 2022, filed 15 Aug 2022.